
Bowmed Ibisqus Ltd is pleased to announce the expansion of its Benzylpenicillin Sodium range with the launch of the 600mg strength in October, following the introduction of the 1200mg strength in August. Both products are supplied in packs of ten glass vials and strengthen our growing portfolio of injectable anti-infective medicines.
Benzylpenicillin sodium, also known as Penicillin G, is a beta-lactam antibiotic from the penicillin class with activity against a wide range of susceptible bacteria. It is used in the treatment of various infections and may also be indicated for serious conditions such as meningitis, septicaemia, anthrax, tetanus, severe Lyme disease, and for the prevention of neonatal group B streptococcal infection. Healthcare professionals should refer to the full prescribing information for complete details of approved indications and use.
This new product is listed with AAH under code BEN0908P (600mg) and BEN0907T (1200mg) and stock is available for customers effective immediately.
If you would like to discuss a pricing arrangement or stock availability for Benzylpenicillin sodium or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us
